Dr. Kingsley Osuala received his Doctor of Philosophy Degree in Biomedical Sciences from the University of Central Florida in 2011. He completed his Postdoctoral work under the guidance of Dr. Bonnie Sloane at Wayne State University (2011–2015). Dr. Osuala has studied breast cancer in the context of how tumors develop and progress in 3D microenvironments. His research has led to the development of novel therapeutics and the development of his biotech company Twelve Biosciences of Michigan.
